Original article Speciation and antifungal susceptibility of esophageal candidiasis in cancer patients in a tertiary care hospital in South India
|
|
- Meredith Porter
- 6 years ago
- Views:
Transcription
1 J M e d A l l i e d S c i ; 6 ( 1 ) : w w w. j m a s. i n P r i n t I S S N : O n l i n e I S S N : X Journal of M e d i cal & Allied Sciences Original article Speciation and antifungal susceptibility of esophageal candidiasis in cancer patients in a tertiary care hospital in South India J. Abirami Lakshmy 1, Radhika Katragadda 2, J. Balaji 3 1 Department of Microbiology, Karpagavinayaga Institute of Medical Sciences, Karpagavinayaga Nagar, Chinnakolambakkam, Palayanoor P.O, Kanchipuram District , Tamil Nadu, India. 2 Department of Microbiology, Government Kilpauk Medical college and Hospital, Chennai , Tamil Nadu, India. 3 Department of Prosthodontics and Implantology, Indira Gandhi Institute of Dental Sciences, MGMCRI campus, Pilaaiyarkuppam, Puducherry , India. Article history: Abstract Received 30 September 2015 Accepted 05 January 2016 Early online 25 January 2016 Print 31 January 2016 Corresponding author J. Abirami Lakshmy Assistant Professor, Department of Microbiology, Karpagavinayaga Institute of Medical Sciences, G.S.T Road, Karpagavinayaga Nagar, Chinnakolambakkam, Palayanoor P.O., Maduranthakam Taluka, Kanchipuram District , Tamil Nadu, India. Phone: Mobile: drabi3285@gmail.com Esophageal candidiasis is the most common opportunistic infection in patients with altered immunity such as HIV infection, cancer patients on chemotherapy and radiotherapy. Neutropenia, irradiation and chemotherapy will facilitate deeper mucosal invasion leading to esophageal candidiasis. Empirical treatment of esophageal candidiasis without antifungal susceptibility testing will lead to the emergence of drug resistant species increasing the morbidity and mortality associated with cancer. The present study aimed to study the frequency of esophageal Candida in individuals with cancer, species level identification and antifungal susceptibility pattern. Scrapings of whitish appearing lesions were obtained from a total of thirty five cases of endoscopically identified esophageal candidiasis were obtained from cancer patients. Identification of the Candida isolates were done by cultivation in Sabouraud dextrose agar (SDA), Gram staining, Germ tube test, colony morphology in Chrom agar and Corn meal agar, sugar assimilation and fermentation tests. Antifungal susceptibility was done by Microbroth dilution method for Fluconazole, Itraconazole and Amphotericin B. We found that Candida albicans was the predominant species isolated followed by Candida tropicalis and Candida glabrata. Sensitivity rates were 94%, 96% and 100% for Fluconazole, Itraconazole and Amphotericin B. Species level identification of Candida isolated from esophageal candidiasis and their antifungal sensitivity testing should be performed for early identification of resistant strains and for promptly treating the cases there by preventing the dissemination of infection in case of immune-compromised individuals. Further the susceptibility pattern will facilitate therapeutic guidance especially in individuals prone to relapse. Key words: Antifungal susceptibility pattern, Cancer patients, Esophageal candidiasis DOI: /jmas Deccan College of Medical Sciences. All rights reserved. 29
2 C andida species were previously thought to be insignificant cause of infection. Gastrointestinal tract serves as a reservoir of Candida. Alteration in immune status will promote the proliferation of endogenous Candida. Candida can cause infections ranging from superficial to deep and disseminated forms involving the internal organs 1,2. Within the past two decades Candida species has emerged as a major human pathogen currently ranked as one of the important cause of nosocomial infection 3. Esophageal candidiasis is one of the most common opportunistic infections in individuals with impaired cellular immunity such as Human Immunodeficiency Virus (HIV) infection, carcinoma, individuals on corticosteroid therapy, chemotherapy and radiotherapy 4,5. Diabetes, acid suppression, steroids, gastric surgery and esophageal motility disorders were also considered as predisposing factor for esophageal candidiasis. Candidiasis can develop secondary to malignancy due to impaired antifungal host defense due to mucosal damage. Esophageal candidiasis might represent a progressive immunity decline 6. Esophageal candidiasis has been reported in 1.4% of stomach cancer cases and in 7.8% of other malignancies 4. Alteration in immune status will promote the proliferation of endogenous Candida and will facilitate deeper mucosal invasion leading to esophageal candidiasis. From the esophagus Candida can spread to distant organs via hematogenous route. Fluconazole is the empirical drug of choice for treating esophageal candidiasis 7. In individuals with cancer there is mucosal disruption facilitating the colonized Candida species to invade deeper tissue leading to esophageal candidiasis or even disseminated candidiasis. Indiscriminately treating all cases of esophageal candidiasis without antifungal susceptibility report can lead to the eradication of drug sensitive species by more inherently resistant species such as Candida krusei and Candida glabrata. Thus the emergence of antifungal drug resistance by the isolates has made invitro antifungal testing methods essential to choose the appropriate antifungal drug and to predict the outcome of therapy. Hence the present study was undertaken to isolate, speciate and to study the antifungal susceptibility pattern of esophageal candidiasis in cancer patients. Materials and methods This observational study was conducted from July 2012 to June The study was approved by the Institutional Ethical Committee. Informed consent was obtained from the patients included in the study. Thirty five cancer patients with endoscopically suspected esophageal candidiasis on treatment with either chemotherapy or radiotherapy and not on any antifungal drugs were included in the study. Esophageal candidiasis was confirmed by the presence of typical coalescent white patches covering the esophageal mucosa. Esophageal scrapings from such lesions were collected in a sterile container and transported to the laboratory as early as possible. Samples were processed for microscopy, culture and characterization of Candida species 8. From each specimen, smears were made on a grease free clean glass slide air dried and heat fixed and staining was done by Gram stain. The presence of Gram positive budding yeast cells with pseudohyphae denotes invasiveness of the Candida indicating infection 8. The material was then inoculated immediately into two sets of Sabouraud Dextrose Agar (SDA) culture tubes and incubated at 25ºC for hours (Growth of the Candida in both the SDA tubes indicate that the strain isolated is not a contaminant but a pathogen). The medium was also supplemented with chloramphenicol (0.05 g/l) to prevent bacterial overgrowth. Growth usually occurs as creamy, white pasty colonies. Gram staining was performed from the colonies for confirmation of presence of Gram positive ovoid 5-7μm sometimes elongated to μm in size 9. Further species identification was done by Germ tube test, growth in Chrom agar based on the color of colonies (HIMEDIA), growth in Corn meal tween 80 Agar (Dalmau Plate Culture Technique), sugar fermentation test and carbohydrate assimilation test as per standard microbiological guidelines 10. Antifungal susceptibility testing was performed by Microbroth dilution method as per Clinical and Laboratory Standards Institute (CLSI) guidelines 10 for Fluconazole, Itraconazole and Amphotericin B 10,11. Sensitivity, specificity and the diagnostic accuracy (Wilson score) of direct Gram staining was analyzed. Antifungal susceptibility testing Antifungal susceptibility testing was performed by Microbroth dilution method using RPMI 1640 with glutamine as per CLSI guidelines (2009) Stock suspension was prepared and diluted with RPMI to obtain an inoculum which contains 1x10 3 to 5x10 3 /ml CFU. Antifungal stock solution was J Med Allied Sci 2016;6(1) 30
3 prepared by dissolving Fluconazole in sterile distilled water. Amphotericin B and Itraconazole were dissolved in Dimethyl sulfoxide. The test was performed in a sterile disposable 96 well microtitre plate. The 2X drug concentration in 100μl volume was dispensed into the wells of row 1 to row 10 of the microtitre plate using a micropipette. Row 1 contained the highest drug concentration and row 10 contained the lowest drug concentration. Each well was inoculated with the 100 μl of 2X inoculum suspension. The growth control well contained 100 μl of sterile drug free medium and the corresponding diluted 2X inoculums suspensions. Row 11 was used to perform the sterility control containing only the drug free medium only. The microtitre plates were incubated at 35ºC for 48 hours. The plates were observed for the presence or absence of visible growth. A numerical score which ranges from 0 to 4 was given to each well 10,11. 0 = Optically clear 1 = Slightly hazy or approximately 25% of growth control 2 = Prominent decrease in turbidity or approximately 50% of growth control 3 = Slight reduction in turbidity or approximately 80% of growth control 4 = No reduction in turbidity End point of MIC Fluconazole and Itraconazole - Score 2 or less Amphotericin B - Score 0 Results A total of 35 endoscopically confirmed cases of esophageal candidiasis among cancer patients were included in the study. The distribution of cases based on the site of malignancy is shown in table 1. Out of the total 35 cases, 15 (42.8%) were suffering from carcinoma esophagus and 14 (40%) were having carcinoma stomach. The age and sex distribution of the patients are depicted in table 2 and 3. Most of the patients (40%) were in the age group of years and 60% of the total cases were male patients. Out of the 15 caricnoma esophagus cases, 13 were adenocarcinoma of lower third of esophagus and two were squamous cell carcinoma. In case of carcinoma stomach all 14 were adenocarcinoma. Out of the 35 cases, 33 (94.2%) were culture positive. Candida albicans was the predominant species isolated 31 (93.3%) followed by one isolate of Candida tropicalis and Candida glabrata each. Direct gram staining was done to look for the presence of Gram positive pseudohyphae and budding yeast cells and it showed a sensitivity and specificity of 100% in comparison with culture. The diagnostic accuracy of direct gram staining was 100% by Wilson score. Since Candida can also be present as a commensal in the gastrointestinal tract, direct Gram staining of the esophageal scrapings can be a valuable tool in the identification of invasive infection. All the culture positive isolates were further identified by Gram staining, Germ tube test (Fig 1), colony morphology on Chrom agar, growth on Corn meal agar, sugar fermentation and assimilation tests as per standard microbiological techniques. On Chrom agar, Candida was speciated on the basis of color of the colonies: light green color (C. albicans), metallic blue color (C. tropicalis) and pink color colonies (C. glabrata) 13. On Corn meal agar speciation was done by presence of terminal chlamydospores (C. albicans) (Fig 2), oval blastoconidia arranged along the hyphae (C. tropicalis) and only the presence of blastoconidia without hyphae (C. glabrata). Sugar fermentation and assimilation tests were interpreted as per standard microbiological techniques (Fig 3). Table 1: Distribution of cases by risk factors Risk factors Number (%) Carcinoma esophagus 15 (42.8%) Carcinoma stomach 14 (40%) Carcinoma pancreas 1 (2.85%) Others 5 (14.28%) Total 35 (100%) Table 2: Age distribution of the patients Age group (in years) Number (%) (8.5%) (40%) (31.4%) (20%) Total 35 (100%) Table 3: Sex distribution of patients Gender Number (%) Male 21 (60%) Female 14 (40%) Total 35 (100%) 31
4 Fig 1. Germ tube test - Candida albicans Fig 2. Candida albicans corn meal agar terminal chlamydospores Fig 3. Candida albicans sugar fermentation reactions (A) and assimilation reactions (B) Antifungal susceptibility testing was done by Microbroth dilution method as per CLSI guidelines for Fluconazole, Itraconazole and Amphotericin B and interpreted as per table 4. Fluconazole and Itraconazole showed 6% and 4% resistance respectively. Both the non-candida albicans isolated were resistant to Fluconazole. All the isolates were sensitive to Amphotericin B as seen in figure 4. By Microbroth dilution method Fluconazole, Itraconazole, Amohotericin B showed a sensitivity of 93.9%, 96.9% and 100% respectively (Fig 5). Discussion Esophageal candidiasis is the most common opportunistic infections in patient with altered immunity such as HIV, individual on corticosteroid therapy chemotherapy and radiotherapy. Development of esophageal candidiasis is a two step process consisting of colonization and subsequent invasion of epithelial layer. Once colonization has been established impaired cellular immunity permits invasion of epithelial layer. Neutropenia, irradiation, chemotherapy will lead to mucosal disruption facilitating deeper invasion of esophagus by Candida. Naito et al 15 and Underwood et al 16 had reported the prevalence of esophageal candidiasis to be 0.71% and 1.17% respectively. Most cases of esophageal candidiasis remain silent and invasion of esophageal wall is usually limited to the superficial epithelium leading on to extensive tissue necrosis and ulceration resulting in esophageal perforation. Candidiasis can develop secondary to malignancy possibly due to impaired antifungal host defense due to mucosal damage 5,17. Candida esophagitis is an important problem in cancer patients. The diagnosis can be missed in some cases leading to more invasive form of infection which can be recalcitrant to treat. In the present study cancer patients with endoscopically diagnosed esophageal candidiasis were included and Candida species causing infection were isolated, identified, characterized and antifungal susceptibility testing was done by Microbroth dilution method. 32
5 Table 4: Antifungal susceptibility testing by Microbroth dilution method - Interpretive criteria 11,14 Antifungal drug Susceptible Susceptible dose dependent Resistant Fluconazole 8μg/ml μg/ml 64 μg/ml Itraconazole μg/ml μg/ml 1 μg/ml Amphotericin B 1 μg/ml - >1 μg/ml consistent with the findings of Wilheim et al 6, Sajith et al 14 (97.4%) and Badarinarayanan et al %. Fig 4. Antifungal susceptibility testing by MIC Amphotericin B % % 99.00% 98.00% 97.00% 96.00% 95.00% 94.00% 93.00% 92.00% 91.00% 90.00% 93.90% 96.90% 100% Fig 5. Antifungal susceptibility pattern by microbroth dilution method In this study all the patients have underwent chemotherapy, steroid therapy and antibiotic treatment. In a study by Sajith et al 14 at Christian Medical College, Vellore, 60 patients with endoscopically suspected esophageal candidiasis with associated risk factors were studied. In that study they have documented that out of the 60 patients eleven individuals were on immunosuppressant therapy and ten had neoplasia. In this study we observed that Candida albicans was the predominant species isolated which is In present study single isolate of Candida tropicalis and Candida glabrata were identified (3.03%). Reports from various parts of the world have indicated the emergence of non-candida albicans species as a cause of infections 16,17. Candida albicans and non-candida albicans differ in their antifungal susceptibility pattern. Few Candida species show innate resistance to drugs like azoles which are usually prescribed as the first line of drug for treating esophageal candidiasis. Empirical treatment with drugs like Fluconazole might eliminate the susceptible species like Candida albicans and promote more discerning growth of species that are naturally resistant like Candida krusei. Prophylactic treatment with antifungal drugs like Fluconazole without analyzing the antifungal susceptibility pattern may escalate the chances of colonization of esophagus by drug resistant non-candida albicans species. Such colonization may lead to invasion of the epithelial layer and development of esophageal candidiasis with drug resistant strains when mucosal disruption occurs such as in the case of malignancy, cancer chemotherapy and irradiation 17. Antifungal susceptibility testing was done by broth microdilution method. Resistance rates were 6% and 4% for Fluconazole and Itraconazole respectively which was consistent with Goldman et al 19 (4%) and Pfaller et al 20. Wilheim et al 6 has reported Fluconazole resistance as 6 (14.28%). All the isolates were susceptible to Amphotericin B. Sajith et al 14 has reported Fluconazole resistance as 59.4% and among the patients with neoplasia resistance to Fluconazole was 50%. Other studies have reported resistance rates varying between 10% and 64% for Fluconazole 20. In our study the two non- Candida albicans isolated were resistant to Fluconazole. Non-Candida albicans isolation in esophageal candidiasis is on the rise. Few species like C. krusei are inherently resistant to azoles, which is of significant concern since they are being used as the first line of drug for the treatment of esophageal candidiasis. In individuals with cancer and those who are on therapy like radiation and chemotherapy mucosal disruption may lead to development of esophageal candidiasis with drug 33
6 resistant isolates. Various studies have documented the prevalence of esophageal candidiasis, its association with different risk factors, species distribution and antifungal susceptibility pattern. In the present study we have studied the species distribution and antifungal susceptibility pattern among a single associated risk factor implicated in esophageal candidiasis i.e. cancer patients on chemotherapy and radiotherapy with altered immune status. For treating such isolates antifungal susceptibility pattern will provide us with an idea to choose the appropriate antifungal drug to prevent further dissemination of the infection which might have serious consequences in immunosuppressed individuals such as in cancer patients. The emergence of antifungal resistance within Candida species, particularly in cancer patients, necessitates routine investigations into antifungal resistance pattern. Such type of studies will facilitate us to get a competent awareness about their drug resistance pattern and may help the physician in selecting the appropriate antifungal agent for empirical therapy. Conclusion Non-Candida albicans is emerging as an important pathogen causing esophageal candidiasis. The finding that significant proportion of Candida albicans showed reduced susceptibility to azoles may have implications for changes in the antifungal drug regimens for treatment. Species level identification and antifungal susceptibility testing is of importance in cancer patients with esophageal candidiasis to prevent invasiveness of the infection. Antifungal susceptibility testing must be done for all the isolates to prevent the emergence of drug resistant isolates. Conflict of interest: Nil Acknowledgements: Nil References 1. Kliemann DA, Pasqualotto AC, Falavigna M, Giaretta T, Severo LC. Candida esophagitis: species distribution and risk factors for infection. Rev Inst Med Trop Sao Paulo. 2008; 50(5): Sahand IH, Maza JL, Eraso E, Montejo M, Moragues MD, Aguirre JM, Quindós G, Pontón J. Evaluation of CHROM- Pal medium for the isolation and direct identification of Candida dubliniensis in primary cultures from the oral cavity. J Med Microbiol. 2009; 58(Pt 11): Pahwa N, Kumar R, Nirkhiwale S, Bandi A. Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore. Indian J Med Microbiol. 2014; 32(1): Choi JH, Lee CG, Lim YJ, Kang HW, Lim CY, Choi JS. Prevalence and risk factors of esophageal candidiasis in healthy individuals: a single center experience in Korea. Yonsei Med J. 2013; 54(1): Samonis G, Skordilis P, Maraki S, Datseris G, Toloudis P, Chatzinikolaou I, Georgoulias V, Bodey GP. Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer. Clin Infect Dis. 1998; 27(2): Wilheim AB, Miranda-Filho Dde B, Nogueira RA, Rêgo RS, Lima Kde M, Pereira LM. The resistance to fluconazole in patients with esophageal candidiasis. Arq Gastroenterol 2009; 46(1): Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson J, Loscalzo J. (Eds.). Harrison s Principles of internal medicine, 18 th edn., New York (NY): Mcgraw Hill, Vol. 1, pp , Merz WG and Hay RJ. Medical Mycology. In: Topley and Wilson Microbiology and Microbial infections, Ch. 1, 10 th edn., London: Edward Arnold Publishers Ltd, pp , Chander J. Textbook of Medical Mycology, Ch. 2, 3 rd edn., Pune: Mehta Publishers, pp , Clinical Laboratory Standards Institute (CLSI). M27-A3 Reference method for broth dilution antifungal susceptibility of yeasts. Approved standard-second edition, Adhikary R and Joshi S. Species distribution and anti-fungal susceptibility of Candidaemia at multi super-speciality center in Southern India. Indian J Med Microbiol. 2011; 29(3): Diekema DJ, Messer SA, Boyken LB, Hollis RJ, Kroeger J, Tendolkar S, Pfaller MA. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. J Clin Microbiol 2009; 47(10): Odds FC and Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994; 32(8): Sajith KG, Dutta AK, Sahni RD, Esakimuthu S, Chacko A. Is empiric therapy with fluconazole appropriate for esophageal candidiasis? Indian J Gastroenterol. 2014; 33(2): Naito Y, Yoshikawa T, Oyamada H, Tainaka K, Morita Y, Kogawa T, Sugino S, Kondo M. Esophageal candidiasis. Gastroenterol Jpn. 1988; 23(4): Underwood JA, Williams JW, Keate RF. Clinical findings and risk factors for Candida esophagitis in outpatients. Dis Esophagus 2003; 16(2): Delsing CE, Bleeker-Rovers CP, van de Veerdonk FL, Tol J, van der Meer JW, Kullberg BJ, Netea MG. Association of esophageal candidiasis and squamous cell carcinoma. Med Mycol Case Rep. 2012; 1(1): Badarinarayanan G, Gowrisankar R, Muthulakshmi K. Esophageal candidiasis in non-immune suppressed patients in a semi-urban town, Southern India. Mycopathologia. 2000; 149(1): Goldman M, Cloud GA, Wade KD, Reboli AC, Fichtenbaum CJ, Hafner R, Sobel JD, Powderly WG, Patterson TF, Wheat LJ, Stein DK, Dismukes WE, Filler SG; AIDS Clinical Trials Group Study Team 323; Mycoses Study Group Study Team 40. A randomized study of the use of fluconazol in contiuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycosis Study Group Study 40. Clin Infect Dis. 2005; 41(10): Pfaller MA, Hollis R, Goldstein BP, Messer S, Diekema D, Henkel T. In vitro activity of anidulafungin and other agents against esophageal candidiasis-associated isolates from a phase 3 clinical trial. J Clin Microbiol. 2010; 48(7):
PREVALANCE OF CANDIDIASIS IN CHILDREN IN MUMBAI
Shrutika Wandre et al. Special Issue, 2015, pp. 25-36 PREVALANCE OF CANDIDIASIS IN CHILDREN IN MUMBAI Shrutika Wandre Department of Clinical Pathology, Haffkine Institute for Training, Research and Testing,
More informationPREVALANCE OF CANDIDIASIS IN CHILDREN IN MUMBAI
Wandre et al., 2015 Volume 1 Issue 1, pp. 25-36 Year of Publication: 2015 DOI- https://dx.doi.org/10.20319/lijshls.2015.s11.2536 This paper can be cited as: Wandre, S., Sanap, S., Mukadam, T., Vaidya,
More informationOriginal Article Characterization of candida species isolated from cases of lower respiratory tract infection
Kathmandu University Medical Journal (2006), Vol. 4, No. 3, Issue 15, 290-294 Original Article Characterization of candida species isolated from cases of lower respiratory tract infection Jha BK 1, Dey
More informationInt.J.Curr.Microbiol.App.Sci (2014) 3(10)
ISSN: 2319-7706 Volume 3 Number 10 (2014) pp. 816-822 http://www.ijcmas.com Original Research Article Identification and In vitro Azole resistance of Candida species isolated from Oropharyngeal Candidiasis
More informationTable 1. Antifungal Breakpoints for Candida. 2,3. Agent S SDD or I R. Fluconazole < 8.0 mg/ml mg/ml. > 64 mg/ml.
AUSTRALIAN ANTIFUNGAL SUSCEPTIBILITY DATA 2008-2011 Part 1: The Yeasts In this article, an update of recent changes to the CLSI antifungal standards for susceptibility testing of yeasts is presented. We
More informationSYNERGISTIC ACTIVITIES OF TWO PROPOLIS WITH AMPHOTERICIN B AGAINST SOME AZOLE-RESISTANT CANDIDA STRAINS. PART II
SYNERGISTIC ACTIVITIES OF TWO PROPOLIS WITH AMPHOTERICIN B AGAINST SOME AZOLE-RESISTANT CANDIDA STRAINS. PART II DURAN NIZAMI 1, MUZ MUSTAFA 2, DURAN GULAY GULBOL 3, OZER BURCIN 1, ONLEN YUSUF 4 1 Mustafa
More informationSpeciation and susceptibility testing of Candida isolates from vaginal discharge
Speciation and susceptibility testing of Candida isolates from vaginal discharge Swapna Muthusamy 1 and Selvi Elangovan 2 1. Sri Venkateshwaraa Medical College Hospital and Research Centre, Puducherry,
More informationSpeciation of Candida Isolated from Various Clinical Samples and their Antifungal Susceptibility Profile in a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 7 (2016) pp. 54-60 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.507.004
More informationAntifungal Susceptibility of Bloodstream Candida Isolates in Pediatric Patients
ISSN: 2319-7706 Volume 4 Number 3 (2015) pp. 716-720 http://www.ijcmas.com Original Research Article Antifungal Susceptibility of Bloodstream Candida Isolates in Pediatric Patients Deepak Kumar 1, Sayan
More information1. Pre-emptive therapy. colonization, colonization, pre-emptive therapy. , ICU colonization. colonization. 2, C. albicans
Jpn. J. Med. Mycol. Vol. 45, 217 221, 2004 ISSN 0916 4804,.,, colonization, pre-emptive therapy. 2, non-albicans Candida., fluconazole.,. Key words: postoperative infection, non-albicans Candida, pre-emptive
More information1* 1. Vijaya S. Rajmane, Shivaji T. Mohite
ISSN 2231-4261 ORIGINAL ARTICLE Comparison of the VITEK 2 Yeast Antifungal Susceptibility ing with CLSI Broth Microdilution Reference for ing Four Antifungal Drugs against Candida species Isolated from
More informationCandida albicans 426 (64.0 ) C. albicans non-albicans
74 2006 1) 2) 1) 3) 4) 5) 6) 1) 2) 3) 4) 5) 6) 17 9 26 18 3 8 2003 10 2004 3 6 9,083 666 (7.3 ) Candida albicans 426 (64.0 ) C. albicans non-albicans 233 (35.0 ) Non-albicans Candida glabrata Candida tropicalis
More informationIsolates from a Phase 3 Clinical Trial. of Medicine and College of Public Health, Iowa City, Iowa 52242, Wayne, Pennsylvania ,
JCM Accepts, published online ahead of print on 26 May 2010 J. Clin. Microbiol. doi:10.1128/jcm.00806-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article In Vitro Antifungal Susceptibility Pattern of Oropharyngeal and Oesophageal Candida Species
More informationOpportunistic Mycoses
CANDIDIASIS SOFYAN LUBIS DEPARTEMEN MIKROBIOLOGI FAK.KEDOKTERAN USU MEDAN 2009 Opportunistic Mycoses Opportunistic mycoses are fungal infections that do not normally cause disease in healthy people, but
More informationIntroduction. Study of fungi called mycology.
Fungi Introduction Study of fungi called mycology. Some fungi are beneficial: ex a) Important in production of some foods, ex: cheeses, bread. b) Important in production of some antibiotics, ex: penicillin
More informationResearch Article Candida glabrata Esophagitis: Are We Seeing the Emergence of a New Azole-Resistant Pathogen?
Microbiology, Article ID 371631, 4 pages http://dx.doi.org/10.1155/2014/371631 Research Article Candida glabrata Esophagitis: Are We Seeing the Emergence of a New Azole-Resistant Pathogen? Aze Wilson,
More informationPrevalence of Oral Thrush Yeasts among School Children with special emphasis of Fluconazole antifungal drug
International Journal of Current Research in Medical Sciences ISSN: 2454-5716 P-ISJN: A4372-3064, E -ISJN: A4372-3061 www.ijcrims.com Original Research Article Volume 3, Issue 3-2017 DOI: http://dx.doi.org/10.22192/ijcrms.2017.03.03.016
More informationPrevalence of Candida infection in HIV seropositive patients in Karur district of Tamil Nadu, India
ISSN: 2319-7706 Volume 3 Number 5 (2014) pp. 312-317 http://www.ijcmas.com Original Research Article Prevalence of Candida infection in HIV seropositive patients in Karur district of Tamil Nadu, India
More informationCHARACTERIZATION AND SUSCEPTIBILITY PATTERN OF CANDIDA ISOLATES FROM HIV - SEROPOSITIVE PATIENTS IN A TERTIARY CARE HOSPITAL
CHARACTERIZATION AND SUSCEPTIBILITY PATTERN OF CANDIDA ISOLATES FROM HIV - SEROPOSITIVE PATIENTS IN A TERTIARY CARE HOSPITAL Apurba Sankar Sastry, Sandhya Bhat K, Anand Sankar Sastry, Kumudavathi M S,
More informationIsolation, speciation and antifungal susceptibility patterns of candida isolated from cases of chronic balanoposthitis
International Journal of Research in Medical Sciences Lakshmi N et al. Int J Res Med Sci. 2016 Jul;4(7):2817-2821 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20161957
More informationRapid Identification and Antifungal Susceptibility Pattern of Candida Isolates from Critically Ill Patients with Candiduria
Original Article Vol. 26 No. 2 Rapid identification and antifungal susceptibility pattern of Candida isolates:- Chaudhary U, et al. 49 Rapid Identification and Antifungal Susceptibility Pattern of Candida
More informationAntifungal susceptibility testing: Which method and when?
Antifungal susceptibility testing: Which method and when? Maiken Cavling Arendrup mad@ssi.dk SSI & Juan Luis Rodriguez Tudela jlrtudela@isciii.es ISCIII Agenda Summary of current standards and selected
More informationCANDIDIASIS (WOMEN) Single Episode. Clinical Features. Diagnosis. Management
CANDIDIASIS (WOMEN) What s new: Section on Management of Vulvovaginal Non-Albicans Candida Infection in Adults approved by GGC antimicrobial team Routine candida sensitivity testing has been discontinued,
More informationMycological Profile of Bronchial Wash Specimens in Patients with Lower Respiratory Tract Infections
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 11 (2017) pp. 176-182 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.611.022
More informationOpen. Abstract. Access
MICROBIOZ JOURNALS Open Access Volume: 1st, Issue: 5 th Microbioz Journals, Journal Of Microbiology and Biomedical Research An open access peer reviewed International Journal Available on : www.microbiozjournals.com
More informationCandida auris: an Emerging Hospital Infection
National Center for Emerging and Zoonotic Infectious Diseases Candida auris: an Emerging Hospital Infection Paige Armstrong MD MHS Epidemic Intelligence Service Officer Mycotic Diseases Branch Association
More informationVoriconazole. Voriconazole VRCZ ITCZ
7 7 8 7 8 fluconazole itraconazole in vitro in vivo Candida spp. C. glabrata C. krusei Cryptococcus neoformans in vitro Aspergillus spp. in vitro in vivo Aspergillus fumigatus Candida albicans C. krusei
More informationOccurrence of Drug Resistant Candida Species in the Sputum of TB Clinic Attendees in and Around Chidambaram, Tamilnadu, India
Journal of Experimental Sciences Vol. 1, Issue 4, Pages 43-47 [2010] www.jexpsciences.com Regular Article Occurrence of Drug Resistant Candida Species in the Sputum of TB Clinic Attendees in and Around
More informationPathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens
Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens Cryptococcus neoformans Candida albicans Aspergillus species Pneumocystis carinii 1 Dermatophytes Named for derma skin Cause
More informationAntifungal Resistance in Asia: Mechanisms, Epidemiology, and Consequences
5th MMTN Conference 5-6 November 2016 Bangkok, Thailand 10:20-10:45, 6 Nov, 2016 Antifungal Resistance in Asia: Mechanisms, Epidemiology, and Consequences Yee-Chun Chen, M.D., PhD. Department of Medicine,
More informationMANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS
MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS Paul D. Holtom, MD Associate Professor of Medicine and Orthopaedics USC Keck School of Medicine Numbers of Cases of Sepsis in the United States, According
More informationVIRULENCE FACTORS AND SUSCEPTIBILITY OF CANDIDA SPP. CAUSATIVE AGENTS OF NEONATAL INFECTIONS
VIRULENCE FACTORS AND SUSCEPTIBILITY OF CANDIDA SPP. CAUSATIVE AGENTS OF NEONATAL INFECTIONS Nikola Stojanović, Predrag Stojanović, Suzana Otašević, Valentina Arsić-Arsenijević What do we know? - Third
More informationIdentification of Yeasts. Medical Mycology Training Network 15 November 2018 Dr Tan Ai Ling Department of Microbiology, Singapore General Hospital
Identification of Yeasts Medical Mycology Training Network 15 November 2018 Dr Tan Ai Ling Department of Microbiology, Singapore General Hospital Definition of Yeasts Eukaryote cells have defined nucleus
More informationDownloaded from Candiduria In Immunocompromised Individuals In A Tertiary Care Center In Northern India
Submitted on: March 2015 Accepted on: March 2015 For Correspondence Email ID: Medrech ISSN No. 2394-3971 Research Article CANDIDURIA IN IMMUNOCOMPROMISED INDIVIDUALS IN A TERTIARY CARE CENTER IN NORTHERN
More informationSusceptibility of Candida Species Isolated From HIV Infected and Newborn Candidaemia Patients to Amphotericin B
OnLine Journal of Biological Sciences 10 (2): 109-113, 2010 ISSN 1608-4217 2010 Science Publications Susceptibility of Candida Species Isolated From HIV Infected and Newborn Candidaemia Patients to Amphotericin
More informationPATHOGENIC CHARACTERISTICS OF Candida albicans ISOLATED FROM ORAL
PATHOGENIC CHARACTERISTICS OF Candida albicans ISOLATED FROM ORAL CAVITIES OF DENTURE WEARERS AND CANCER PATIENTS WEARING ORAL PROSTHESES Junior Vivian Mothibe A dissertation submitted to the Faculty of
More informationOral Candidal and Streptococcal carriage in Down syndrome patients
Original Article Oral Candidal and Streptococcal carriage in Down syndrome patients Gouse Mohiddin, Aravindha Babu Narayanaswamy 1, Masthan K. M. K. 1, Anitha Nagarajan 1, Abikshyeet Panda, Shyam Sundar
More informationPhospholipase activity of Candida albicans isolated from vagina and urine samples
Ali Zarei Mahmoudabadi, et al. 169 Original article Phospholipase activity of Candida albicans isolated from vagina and urine samples Ali Zarei Mahmoudabadi* 1,2, Majid Zarrin 2, Sanaz Miry 2 1 Infectious
More informationReceived 18 December 2008/Returned for modification 9 February 2009/Accepted 9 April 2009
JOURNAL OF CLINICAL MICROBIOLOGY, June 2009, p. 1942 1946 Vol. 47, No. 6 0095-1137/09/$08.00 0 doi:10.1128/jcm.02434-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Activity
More informationA CASE REPORT OF: PSEUDOMEMBRANOUS CANDIDIASIS INDUCED BY LONG TERM SYSTEMIC CORTICOSTEROIDS THERAPY
Case Report International Journal of Dental and Health Sciences Volume 02, Issue 02 A CASE REPORT OF: PSEUDOMEMBRANOUS CANDIDIASIS INDUCED BY LONG TERM SYSTEMIC CORTICOSTEROIDS THERAPY Ziad Salim Abdul
More informationSpecies Distribution and Antifungal Drug Susceptibility of Candida in Clinical Isolates from a Tertiary Care Centre at Bareilly
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 1 Ver. II (January. 2017), PP 57-61 www.iosrjournals.org Species Distribution and Antifungal
More informationISOLATION AND RAPID IDENTIFICATION OF CANDIDA SPECIES FROM THE ORAL CAVITY
ISSN Print/Online: 2320-9577/2320-9585 INTERNATIONAL JOURNAL OF PURE AND APPLIED ZOOLOGY Volume 1, Issue 2, June 2013 Available online at: http://www.ijpaz.com RISHAN PUBLICATIONS RESEARCH ARTICLE OPEN
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE CLINICO- MYCOLOGICAL PROFILE OF CANDIDIASIS IN LEUCORRHOEA CASES Dr. B. MADHUMATI, Dr. J. NAGA SUDHA RANI, Dr. N. SUNEETA, Dr. K. H. VASUDEVA
More informationInt.J.Curr.Res.Aca.Rev.2017; 5(9): 10-14
International Journal of Current Research and Academic Review ISSN: 2347-3215 (Online) Volume 5 Number 9 (September-2017) Journal homepage: http://www.ijcrar.com doi: https://doi.org/10.20546/ijcrar.2017.509.002
More informationReceived 12 December 2010/Returned for modification 5 January 2011/Accepted 16 March 2011
JOURNAL OF CLINICAL MICROBIOLOGY, May 2011, p. 1765 1771 Vol. 49, No. 5 0095-1137/11/$12.00 doi:10.1128/jcm.02517-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Multicenter
More informationAntifungal susceptibility testing using the E test: comparison with the broth macrodilution technique
Journal of Antimicrobial Chemotherapy (996) 7, 65-7 Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique Sharon C. A. Chen, Maryann L. O'Donnell, Suzannah
More informationIsolation and Rapid identification of Candida species from the Oral cavity
Available online at www.ijpab.com ISSN: 2320 7051 Int. J. Pure App. Biosci. 1 (3): 23-27 (2013) Research Article International Journal of Pure & Applied Bioscience Isolation and Rapid identification of
More informationInternational Journal of Allied Medical Sciences
International Journal of Allied Medical Sciences and Clinical Research (IJAMSCR) IJAMSCR Volume 3 Issue 1 Jan-Mar- 2015 www.ijamscr.com Research article Health research Asymptomatic candiduria in HIV seropositives
More informationComparison of microdilution method and E-test procedure in susceptibility testing of caspofungin against Candida non-albicans species
NEW MICROBIOLOGICA, 31, 257-262, 2008 Comparison of microdilution method and E-test procedure in susceptibility testing of caspofungin against Candida non-albicans species Anna Serefko, Renata Los, Anna
More informationNational Center for Emerging and Zoonotic Infectious Diseases AR Lab Network Candida Testing
National Center for Emerging and Zoonotic Infectious Diseases AR Lab Network Candida Testing Snigdha Vallabhaneni, MD, MPH Medical Epidemiologist Centers for Disease Control and Prevention Invasive Candidiasis
More informationPrevalence and Risk Factors of Esophageal Candidiasis in Healthy Individuals: A Single Center Experience in Korea
Original Article http://dx.doi.org/10.3349/ymj.2013.54.1.160 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 54(1):160-165, 2013 Prevalence and Risk Factors of Esophageal Candidiasis in Healthy Individuals:
More informationStaphylococci. Gram stain: gram positive cocci arranged in clusters.
Microbiology lab Respiratory system Third medical year Lab contents: Gram positive bacteria (Staphylococcus and Streptococcus spp), two types of filamentous fungi (Aspergillus and Penicillium spp), and
More information9/18/2018. Invasive Candidiasis. AR Lab Network Candida Testing. Most Common Healthcare Associated Bloodstream Infection in the United States?
National Center for Emerging and Zoonotic Infectious Diseases AR Lab Network Candida Testing Invasive Candidiasis Snigdha Vallabhaneni, MD, MPH Medical Epidemiologist Centers for Disease Control and Prevention
More informationAn Update in the Management of Candidiasis
An Update in the Management of Candidiasis Daniel B. Chastain, Pharm.D., AAHIVP Infectious Diseases Pharmacy Specialist Phoebe Putney Memorial Hospital Adjunct Clinical Assistant Professor UGA College
More informationPrevalence of Candida co-infection in patients with pulmonary tuberculosis
Prevalence of Candida co-infection in patients with pulmonary tuberculosis Arunava Kali, MV Pravin Charles, Noyal Mariya Joseph, Sivaraman Umadevi, Shailesh Kumar, Joshy M Easow Department of Microbiology,
More informationA study on fluconazole resistance among candida species isolated from patients attending STD OPD in a tertiary care hospital
Original Research Article A study on fluconazole resistance among candida species isolated from patients attending STD OPD in a tertiary care hospital Kavitha M 1*, Hemalatha S 2, Shanmugapriya V 3 1 Associate
More informationSensitivity of Candida albicans isolates to caspofungin comparison of microdilution method and E-test procedure
Basic research Sensitivity of Candida albicans isolates to caspofungin comparison of microdilution method and E-test procedure Anna Serefko, Anna Malm Department of Pharmaceutical Microbiology, Medical
More informationCandida albicans. Habitat, Morphology, Cultural Characteristics, Life Cycle, Pathogenesis, Lab Diagnosis, Treatments, Prevention and Control
Candida albicans Habitat, Morphology, Cultural Characteristics, Life Cycle, Pathogenesis, Lab Diagnosis, Treatments, Prevention and Control Habitat of Candida albicans - Normal Habitat: mucosal membranes
More informationAntifungal Pharmacodynamics A Strategy to Optimize Efficacy
Antifungal Pharmacodynamics A Strategy to Optimize Efficacy David Andes, MD Associate Professor, Department of Medicine Division of Infectious Diseases Medical Microbiology and Immunology University of
More informationNosocomial Candidemia in intensive care units of a tertiary care hospital, New Delhi, India
ISSN: 2319-7706 Volume 3 Number 6 (2014) pp. 513-517 http://www.ijcmas.com Original Research Article Nosocomial Candidemia in intensive care units of a tertiary care hospital, New Delhi, India Priyanka
More informationCandida glabrata: Review of Epidemiology, Pathogenesis, and Clinical Disease with Comparison to C. albicans
CLINICAL MICROBIOLOGY REVIEWS, Jan. 1999, p. 80 96 Vol. 12, No. 1 0893-8512/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Candida glabrata: Review of Epidemiology,
More informationAntifungal Activity of Voriconazole on Local Isolates: an In-vitro Study
Original Article Philippine Journal of OPHTHALMOLOGY Antifungal Activity of Voriconazole on Local Isolates: an In-vitro Study Karina Q. De Sagun-Bella, MD, 1 Archimedes Lee D. Agahan, MD, 1 Leo DP. Cubillan,
More informationTitle: Author: Speciality / Division: Directorate:
Antifungal guidelines for CANDIDIASIS INFECTIONS (Adults) Proven infection: Targeted antifungal therapy should be prescribed for: o Positive cultures from a sterile site with clinical or radiological abnormality
More informationPrevalence, Distribution, Risk factors and Antifungal Susceptibility Profiles of Candida species in a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 4 (2016) pp. 329-337 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.504.039
More informationINFLUENCE OF ASSOCIATING NONSTEROIDAL ANTI-INFLAMMATORY DRUGS WITH ANTIFUNGAL COMPOUNDS ON VIABILITY OF SOME CANDIDA STRAINS
5 REFERATE GENERALE INFLUENCE OF ASSOCIATING NONSTEROIDAL ANTI-INFLAMMATORY DRUGS WITH ANTIFUNGAL COMPOUNDS ON VIABILITY OF SOME CANDIDA STRAINS Elena Rusu 1, Ionela Sarbu 2, Diana Pelinescu 2, Ioana Nedelcu
More informationMicafungin and Candida spp. Rationale for the EUCAST clinical breakpoints. Version February 2013
Micafungin and Candida spp. Rationale for the EUCAST clinical breakpoints. Version 1.0 5 February 2013 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised
More informationDermatophytes Dr. Hala Al Daghistani
Dermatophytes Dr. Hala Al Daghistani Dermatophytoses are superficial infections of the skin and its appendages, commonly known as ringworm, athlete s foot, and jock itch. They are caused by species of
More informationTrichophyton Microsporum Epidermophyton. dermatomycosis. Dematiaceous(pigmented fungi ) Dimorphic fungi Yeast and yeast like saprophyte
Cutaneous candidiasis dermatophytosis Trichophyton Microsporum Epidermophyton dermatomycosis Dematiaceous(pigmented fungi ) Dimorphic fungi Yeast and yeast like saprophyte dermatomycosis Yeast & yeast
More informationISSN Vol.02,Issue.19, December-2013, Pages:
www.semargroups.org, www.ijsetr.com ISSN 2319-8885 Vol.02,Issue.19, December-2013, Pages:2180-2185 Studies on Antifungal Properties of Some Plant Extracts (Garlic, Fenugreek, Ginger) Against of Clinical
More informationOropharyngeal Candidiasis in HIV/AIDS: A hospital based co-relation study
ISSN: 2319-7706 Volume 3 Number 4 (2014) pp. 135-140 http://www.ijcmas.com Original Research Article Oropharyngeal Candidiasis in HIV/AIDS: A hospital based co-relation study Debkumar Ray 1* and Debashis
More informationFKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia
Clinical Infectious Diseases Advance Access published July 9, 2014 MAJOR ARTICLE FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia Nicholas D. Beyda, 1 Julie John, 1 Abdullah
More informationFungi GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Fungi Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA Chapter Editor Ziad A. Memish, MD, FRCPC, FACP Cover heading - Topic Outline Topic outline
More informationENG MYCO WELL D- ONE REV. 1.UN 29/09/2016 REF. MS01283 REF. MS01321 (COMPLETE KIT)
ENG MYCO WELL D- ONE MYCO WELL D-ONE System for the presumptive identification and antimicrobial susceptibility test of urogenital mycoplasmas, Gardnerella vaginalis, Trichomonas vaginalis, Candida albicans
More informationEfficacy of a Novel Echinocandin, CD101, in a Mouse Model of Azole-Resistant Disseminated Candidiasis
Efficacy of a Novel Echinocandin, CD0, in a Mouse Model of Azole-Resistant Disseminated Candidiasis L. Miesel, K-Y Lin, J. C. Chien, M. L. Hsieh, V. Ong, and K. Bartizal Eurofins Panlabs, Taipei, Taiwan
More informationNationwide survey of treatment for pediatric patients with invasive fungal infections in Japan
J Infect Chemother (2013) 19:946 950 DOI 10.1007/s10156-013-0624-7 ORIGINAL ARTICLE Nationwide survey of treatment for pediatric patients with invasive fungal infections in Japan Masaaki Mori Received:
More informationINCIDENCE OF CURVULARIA ORGANISM IN MYCOTIC CORNEAL ULCER K. Anjaneyulu 1, Balla Vidya Sagar 2
INCIDENCE OF CURVULARIA ORGANISM IN MYCOTIC CORNEAL ULCER K. Anjaneyulu 1, Balla Vidya Sagar 2 HOW TO CITE THIS ARTICLE: K. Anjaneyulu, Balla Vidya Sagar. Incidence of Curvularia Organism in Mycotic Corneal
More informationCase presentations: The pitfalls in diagnosis and management of oral lesions in cancer patients
Case presentations: The pitfalls in diagnosis and management of oral lesions in cancer patients Siri Beier Jensen Associate Professor, DDS, PhD Aarhus University Faculty Disclosure X No, nothing to disclose
More informationnumber Done by Corrected by Doctor د.حامد الزعبي
number Fungi#1 Done by نرجس الس ماك Corrected by مهدي الشعراوي Doctor د.حامد الزعبي Introduction to Mycology -Terms: -Medical Mycology: The study of mycosis and their etiological agents -Mycosis: Disease
More informationAntifungal Stewardship. Önder Ergönül, MD, MPH Koç University, School of Medicine, Istanbul 6 October 2017, ESGAP course, Istanbul
Antifungal Stewardship Önder Ergönül, MD, MPH Koç University, School of Medicine, Istanbul 6 October 2017, ESGAP course, Istanbul 1 2 Objectives What do we know? Invasive Candida and Aspergillosis Impact
More informationComparative study of invasive methods for diagnosis of Helicobacter pylori in humans
ISSN: 2319-7706 Volume 2 Number 7 (2013) pp. 63-68 http://www.ijcmas.com Original Research Article Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans V.Subbukesavaraja
More informationCan the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar?
Can the diagnosis of recurrent vulvovaginal candidosis be improved by use of vaginal lavage samples and cultures on chromogenic agar? Novikova, N; Rodrigues, A; Mårdh, Per-Anders Published in: Infectious
More informationEFFICACY OF ITRACONAZOLE VERSUS FLUCONAZOLE IN VULVOVAGINAL CANDIDIASIS: AN IN VIVO STUDY Amit Tolasaria 1, Nupur Nandi 2
EFFICACY OF ITRACONAZOLE VERSUS FLUCONAZOLE IN VULVOVAGINAL CANDIDIASIS: AN IN VIVO STUDY Amit Tolasaria 1, Nupur Nandi 2 HOW TO CITE THIS ARTICLE: Amit Tolasaria, Nupur Nandi. Efficacy of Itraconazole
More informationUpdate zu EUCAST 2012 Cornelia Lass-Flörl
Update zu EUCAST 2012 Cornelia Lass-Flörl Frühjahrstagung 2012 Paul-Ehrlich-Gesellschaft Sektion Antimykotische Chemotherapie Bonn, 4./5. Mai 2012 Agenda 1. Breakpoints 2. Rationale documents and technical
More informationFungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia
Fungal infections in ICU Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia Epidemiology of invasive fungal infections - US +300% Martin GS, et al. N Engl J Med 2003;348:1546-1554
More informationCandida albicans and non-candida albicans Candida species on acrylic substrate
www.scielo.br/jaos Candida albicans and non-candida albicans Candida species on acrylic substrate 1 2 3 1- MSc. PhD, Sr. Lecturer, Department of Microbiology, Modern Dental College & Research Centre, Indore
More informationEpidemiological Study on Candida Species in Patients with Cancer in the Intensive Care Unit
ORIGINAL ARTICLE Public Health Res Perspect 2017;8(6):384 388 eissn 2233-6052 Epidemiological Study on Candida Species in Patients with Cancer in the Intensive Care Unit Young-ju Choi a, Byeongyeo Lee
More informationIsolation and Identification of Dermatophytes from Clinical Samples One Year Study
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 11 (2017) pp. 1276-1281 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.611.152
More informationRapid Species Identification and Antifungal Susceptibility Testing of Candida Isolated from Different Hospital Acquired Infections by VITEK 2 System
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 11 (2017) pp. 764-772 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.611.090
More informationInternational Journal of Scientific & Engineering Research, Volume 7, Issue 8, August ISSN
International Journal of Scientific & Engineering Research, Volume 7, Issue 8, August-2016 105 Antimicrobial activity of Andrographis paniculata stem extracts. S.Gurupriya 1 and Dr.L.Cathrine 2 1 M.phil
More informationCase Studies in Fungal Infections and Antifungal Therapy
Case Studies in Fungal Infections and Antifungal Therapy Wayne L. Gold MD, FRCPC Annual Meeting of the Canadian Society of Internal Medicine November 4, 2017 Disclosures No financial disclosures or industry
More informationCandida auris - an update on a globally emerging pathogen
Candida auris - an update on a globally emerging pathogen Dr Elizabeth M. Johnson Public Health England Mycology Reference Laboratory Bristol Scottish Microbiology and Virology Network Meeting 2017 Disclosures
More informationAntimicrobial Activity of the Anthocyanins Isolated from Purple Field Corn (Zea mays L.) Cob against Candida spp.
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn: 2278-3008, p-issn:2319-7676. Volume 9, Issue 4 Ver. II (Jul -Aug. 2014), PP 40-44 Antimicrobial Activity of the Anthocyanins Isolated
More informationEchinocandin Susceptibility Testing of Candida Isolates Collected during a 1-Year Period in Sweden
JOURNAL OF CLINICAL MICROBIOLOGY, July 2011, p. 2516 2521 Vol. 49, No. 7 0095-1137/11/$12.00 doi:10.1128/jcm.00201-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Echinocandin
More informationWeds. Date. Aug. 26. Sept. 2
Mt.SanAntonioCollege Microbiology 22 Lab Schedule for Fall 2015 Mon./ Split Lab Sections ONLY Wk. Mon. 1 Aug. 24 Orientation with Introductions & Safety Rules/Regulations 2 Aug. 31 Exercise #1: The Microscope
More informationCHAPTER 8 ANTIBACTERIAL ACTIVITY OF THE CRUDE ETHANOLIC EXTRACT AND THE ISOLATED COMPOUNDS FROM THE STEM OF COSTUS IGNEUS
CHAPTER 8 ANTIBACTERIAL ACTIVITY OF THE CRUDE ETHANOLIC EXTRACT AND THE ISOLATED COMPOUNDS FROM THE STEM OF COSTUS IGNEUS 8.1 INTRODUCTION Medicinal plants are the backbone of traditional medicine and
More informationCandidemia: New Sentinel Surveillance in the 7-County Metro
Candidemia: New Sentinel Surveillance in the 7-County Metro Brittany VonBank, MPH Paula Vagnone, MT (ASCP) 651-201-5414 www.health.state.mn.us Health Care-associated Infections & Antimicrobial Resistance
More information7/13/09. Definition. Infections Due to Malassezia. Case Report 1. Case Report 1 (cont.) Case Report 1 (cont.)
Definition Infections Due to Malassezia Various species of Malassezia cause both opportunistic, superficial infections and occasionally systemic infections Common superficial infections include: Pityriasis
More informationMt. San Antonio College Microbiology 22 Lab Schedule for Spring 2018 Mon/Weds. Split Lab Sections ONLY
Mt. San Antonio College Microbiology 22 Lab Schedule for Spring 2018 Mon/ Split Lab Sections ONLY Wk 1 Feb. 26 Orientation with Introductions & Safety Rules/Regulations Feb. 28 Orientation with Pathogen
More information